| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |